Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus etomidate for anesthesia in elderly prostate biopsy
ChiCTR2400091993Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and etomidate (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Postoperative recovery time. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
remimazolametomidate
Beyond the preview
Go deeper on ChiCTR2400091993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091993.